Patel Dinesh V Ph D - Net Worth and Insider Trading
Patel Dinesh V Ph D Net Worth
The estimated net worth of Patel Dinesh V Ph D is at least $16 Million dollars as of 2024-05-12. Patel Dinesh V Ph D is the President and CEO of Protagonist Therapeutics Inc and owns about 549,590 shares of Protagonist Therapeutics Inc (PTGX) stock worth over $16 Million. Details can be seen in Patel Dinesh V Ph D's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Patel Dinesh V Ph D has not made any transactions after 2024-04-01 and currently still holds the listed stock(s).
Transaction Summary of Patel Dinesh V Ph D
Patel Dinesh V Ph D Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Patel Dinesh V Ph D owns 1 companies in total, including Protagonist Therapeutics Inc (PTGX) .
Click here to see the complete history of Patel Dinesh V Ph D’s form 4 insider trades.
Insider Ownership Summary of Patel Dinesh V Ph D
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTGX | Protagonist Therapeutics Inc | 2024-04-01 | director & President and CEO |
Patel Dinesh V Ph D Latest Holdings Summary
Patel Dinesh V Ph D currently owns a total of 1 stock. Patel Dinesh V Ph D owns 549,590 shares of Protagonist Therapeutics Inc (PTGX) as of April 1, 2024, with a value of $16 Million.
Latest Holdings of Patel Dinesh V Ph D
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics Inc | 2024-04-01 | 549,590 | 28.23 | 15,514,926 |
Holding Weightings of Patel Dinesh V Ph D
Patel Dinesh V Ph D Form 4 Trading Tracker
According to the SEC Form 4 filings, Patel Dinesh V Ph D has made a total of 7 transactions in Protagonist Therapeutics Inc (PTGX) over the past 5 years, including 1 buys and 6 sells. The most-recent trade in Protagonist Therapeutics Inc is the sale of 25,000 shares on April 1, 2024, which brought Patel Dinesh V Ph D around $707,750.
Insider Trading History of Patel Dinesh V Ph D
- 1
Patel Dinesh V Ph D Trading Performance
GuruFocus tracks the stock performance after each of Patel Dinesh V Ph D's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patel Dinesh V Ph D is 70.15%. GuruFocus also compares Patel Dinesh V Ph D's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patel Dinesh V Ph D within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Patel Dinesh V Ph D's insider trading performs compared to the benchmark.
Performance of Patel Dinesh V Ph D
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 40.51 | | | | | |
| Relative Return to S&P 500(%) | 35.93 | | | | | |
Patel Dinesh V Ph D Ownership Network
Patel Dinesh V Ph D Owned Company Details
What does Protagonist Therapeutics Inc do?
Who are the key executives at Protagonist Therapeutics Inc?
Patel Dinesh V Ph D is the director & President and CEO of Protagonist Therapeutics Inc. Other key executives at Protagonist Therapeutics Inc include Chief Financial Officer Asif Ali , Chief Development Officer Suneel Gupta , and Chief Medical Officer Arturo Md Molina .
Protagonist Therapeutics Inc (PTGX) Insider Trades Summary
Over the past 18 months, Patel Dinesh V Ph D made 3 insider transaction in Protagonist Therapeutics Inc (PTGX) with a net sale of 130,000. Other recent insider transactions involving Protagonist Therapeutics Inc (PTGX) include a net sale of 25,421 shares made by Asif Ali , a net sale of 12,975 shares made by William D. Waddill , and a net sale of 5,000 shares made by Suneel Gupta .
In summary, during the past 3 months, insiders sold 93,396 shares of Protagonist Therapeutics Inc (PTGX) in total and bought 0 shares, with a net sale of 93,396 shares. During the past 18 months, 175,244 shares of Protagonist Therapeutics Inc (PTGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 175,244 shares.
Protagonist Therapeutics Inc (PTGX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protagonist Therapeutics Inc Insider Transactions
Patel Dinesh V Ph D Mailing Address
Above is the net worth, insider trading, and ownership report for Patel Dinesh V Ph D. You might contact Patel Dinesh V Ph D via mailing address: C/o Protagonist Therapeutics, Inc., 521 Cottonwood Drive, Suite 100, Milpitas Ca 95035.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
